Study links protein to MDS survival rate, progression to AML

10/6/2011 | MDSBeacon.com

Taiwanese researchers have discovered that people with myelodysplastic syndromes who have lower levels of the angiopoietin-1 protein were less likely to progress to acute myeloid leukemia and survived longer compared with patients who had higher levels of the protein. The protein plays a role in the formation of new blood vessels, according to the study published in the British Journal of Cancer.

View Full Article in:

MDSBeacon.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations